Cerebral Microbleeds and Thrombolysis-Associated Intracerebral Hemorrhage: Cause for Concern, or Just a Distraction? David J. Werring, PhD...

Size: px
Start display at page:

Download "Cerebral Microbleeds and Thrombolysis-Associated Intracerebral Hemorrhage: Cause for Concern, or Just a Distraction? David J. Werring, PhD..."

Transcription

1 Stroke AN AHA/ASA JO U R N A L Volume 46 Number 9 September 2015 This article contains online supplementary information that is available at In Memoriam Dan Adams Bugher Foundation Champion for Training and Collaboration Ralph L. Sacco, MS, MD; Jaime Aron, BJ Editorial Cerebral Microbleeds and Thrombolysis-Associated Intracerebral Hemorrhage: Cause for Concern, or Just a Distraction? David J. Werring, PhD Stroke: Highlights of Selected Articles Original Contributions Clinical Sciences Genetic Architecture of Lacunar Stroke Matthew Traylor, PhD; Steve Bevan, PhD; Jean-Claude Baron, ScD; Ahamad Hassan, MD; Cathryn M. Lewis, PhD; Hugh S. Markus, DM Long-Term Blood Brain Barrier Permeability Changes in Binswanger Disease Branko N. Huisa, MD; Arvind Caprihan, PhD; Jeffrey Thompson, BS; Jillian Prestopnik, PhD; Clifford R. Qualls, PhD; Gary A. Rosenberg, MD Elevated Total Homocysteine Levels in Acute Ischemic Stroke Are Associated With Long-Term Mortality Zhihong Shi, MD, PhD; Yalin Guan, MD, MS; Ya Ruth Huo, BA, MD; Shuling Liu, RN, MS; Meilin Zhang, PhD; Hui Lu, MD, MS; Wei Yue, MD, MS; Jinhuan Wang, MD, PhD; Yong Ji, MD, PhD Copeptin Levels in Patients With Acute Ischemic Stroke and Stroke Mimics Matthias Wendt, MD; Martin Ebinger, MD; Alexander Kunz, MD; Michal Rozanski, MD; Carolin Waldschmidt, MD; Joachim E. Weber, MD; Benjamin Winter, MD; Peter M. Koch, MD; Christian H. Nolte, MD; Sabine Hertel, PhD; Tim Ziera, PhD; Heinrich J. Audebert, MD; for the STEMO Consortium Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study Laurent Fauchier, MD; Nicolas Clementy, MD; Christele Pelade, PhD; Cecile Collignon, PharmD; Emmanuelle Nicolle, MD, MSc; Gregory Y.H. Lip, MD Role of Acute Lesion Topography in Initial Ischemic Stroke Severity and Long-Term Functional Outcomes Ona Wu, PhD; Lisa Cloonan, BA; Steven J.T. Mocking, MS; Mark J.R.J. Bouts, PhD; William A. Copen, MD; Pedro T. Cougo-Pinto, MD; Kaitlin Fitzpatrick, BS; Allison Kanakis, MD; Pamela W. Schaefer, MD; Jonathan Rosand, MD, MSc; Karen L. Furie, MD, MPH; Natalia S. Rost, MD, MPH STROKE (ISSN ) is published monthly by Lippincott Williams & Wilkins, at Hunters Green Parkway, Hagerstown, MD Business offices are located at Two Commerce Square, 2001 Market Street, Philadelphia, PA Production offices are located at 351 West Camden Street, Baltimore, MD In the US, individuals may subscribe in print for their personal use at the following annual rates: $249 for members of any American Heart Association (AHA) scientific council or $528 for non-members. International: $329 for AHA members or $654 for non-members. Online-only and other additional rates can be found online at AHA membership information can be found online at Periodicals postage paid at Hagerstown, MD, and additional mailing offices. POSTMASTER: Send address changes to STROKE, American Heart Association, Lippincott Williams & Wilkins, Hunters Green Parkway, Hagerstown, MD

2 Remote Ischemic Conditioning Alters Methylation and Expression of Cell Cycle Genes in Aneurysmal Subarachnoid Hemorrhage Elina Nikkola, BS; Azim Laiwalla, MS; Arthur Ko, BS; Marcus Alvarez, BS; Mark Connolly, BS; Yinn Cher Ooi, MD; William Hsu, PhD; Alex Bui, PhD; Päivi Pajukanta, MD, PhD; Nestor R. Gonzalez, MD Clipping and Coiling of Unruptured Intracranial Aneurysms Among Medicare Beneficiaries, 2000 to 2010 Jessica J. Jalbert, PhD; Abby J. Isaacs, MSc; Hooman Kamel, MD; Art Sedrakyan, MD, PhD Microbleed Status and 3-Month Outcome After Intravenous Thrombolysis in 717 Patients With Acute Ischemic Stroke Guillaume Turc, MD; Asmaa Sallem, MD; Solène Moulin, MD; Marie Tisserand, MD; Alexandre Machet, MD; Myriam Edjlali, MD; Jean-Claude Baron, ScD; Xavier Leclerc, PhD; Didier Leys, PhD; Jean-Louis Mas, MD; Charlotte Cordonnier, PhD; Catherine Oppenheim, PhD CME High-Resolution Intracranial Pressure Burden and Outcome in Subarachnoid Hemorrhage Federico Magni, MD; Matteo Pozzi, MD; Matteo Rota, PhD; Alessia Vargiolu, PhD; Giuseppe Citerio, MD Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR III Alastair J.S. Webb, DPhil; Natalie L. Ullman, BS; Tim C. Morgan, MPH; John Muschelli, ScM; Joshua Kornbluth, MD; Issam A. Awad, MD; Stephen Mayo, MD; Michael Rosenblum, PhD; Wendy Ziai, MD; Mario Zuccarrello, MD; Francois Aldrich, MD; Sayona John, MD; Sagi Harnof, MD; George Lopez, MD; William C. Broaddus, MD; Christine Wijman, MD; Paul Vespa, MD; Ross Bullock, MD, PhD; Stephen J. Haines, MD; Salvador Cruz-Flores, MD; Stan Tuhrim, MD; Michael D. Hill, MD; Raj Narayan, MD; Daniel F. Hanley, MD; for the MISTIE and CLEAR Investigators Risk Factors of Ischemic Stroke and Subsequent Outcome in Patients Receiving Hemodialysis Mark D. Findlay, MBChB, MRCP; Peter C. Thomson, MD; Rachael L. Fulton, PhD; Marit D. Solbu, PhD; Alan G. Jardine, MD; Rajan K. Patel, PhD, MRCP; Kathryn K. Stevens, PhD, MRCP; Colin C. Geddes, MBChB; Jesse Dawson, MD; Patrick B. Mark, PhD Prognostic Significance of Short-Term Blood Pressure Variability in Acute Stroke: Systematic Review Lisa S. Manning, MBChB; Peter M. Rothwell, FMedSci; John F. Potter, DM; Thompson G. Robinson, MD Recurrent Stroke: The Value of the CHA 2 DS 2 VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort Søren Due Andersen, MD; Anders Gorst-Rasmussen, MSc, PhD; Gregory Y.H. Lip, MD; Flemming W. Bach, MD, DMSc; Torben Bjerregaard Larsen, MD, PhD Rate of Contrast Extravasation on Computed Tomographic Angiography Predicts Hematoma Expansion and Mortality in Primary Intracerebral Hemorrhage H. Bart Brouwers, MD, PhD; Thomas W.K. Battey, BS; Hayley H. Musial, BA; Viesha A. Ciura, MD; Guido J. Falcone, MD, PhD, MPH; Alison M. Ayres, BA; Anastasia Vashkevich, BA; Kristin Schwab, BA; Anand Viswanathan, MD, PhD; Christopher D. Anderson, MD; Steven M. Greenberg, MD, PhD; Stuart R. Pomerantz, MD; Claudia J. Ortiz, MD; Joshua N. Goldstein, MD, PhD; R. Gilberto Gonzalez, MD, PhD; Jonathan Rosand, MD, MSc; Javier M. Romero, MD Intracranial Carotid Calcification on Cranial Computed Tomography: Visual Scoring Methods, Semiautomated Scores, and Volume Measurements in Patients With Stroke Deepak Subedi, FRCR; Umme Sara Zishan, MBBS; Francesca Chappell, PhD; Maria-Lena Gregoriades, FRCR; Cathie Sudlow, DPhil; Robin Sellar, FRCR; Joanna Wardlaw, FRCR, MD Younger Stroke Patients With Large Pretreatment Diffusion-Weighted Imaging Lesions May Benefit From Endovascular Treatment Marc D. Gilgen, MSc; Dariusz Klimek; Kai T. Liesirova, MD; Julia Meisterernst; Pascal P. Klinger-Gratz, MD; Gerhard Schroth, MD; Pasquale Mordasini, MD; Kety Hsieh, MD; Johannes Slotboom, PhD; Mirjam R. Heldner, MD; Anne Broeg-Morvay; Marie-Luise Mono, MD; Urs Fischer, MD; Heinrich P. Mattle, MD; Marcel Arnold, MD; Jan Gralla, MD; Marwan El-Koussy, MD; Simon Jung, MD Combined Multimodal Computed Tomography Score Correlates With Futile Recanalization After Thrombectomy in Patients With Acute Stroke Mariano Espinosa de Rueda, MD; Guillermo Parrilla, PhD; Sergio Manzano-Fernández, PhD; Blanca García-Villalba, MD; Joaquín Zamarro, MD; Francisco Hernández-Fernández, PhD; Cristina Sánchez-Vizcaino, MD; Ester Carreón, MD; Ana Morales, PhD; Antonio Moreno, MD

3 Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial Keitaro Senoo, MD; Gregory Y.H. Lip, MD; Deirdre A. Lane, PhD; Harry R. Büller, PhD; Dipak Kotecha, PhD Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial Opeolu Adeoye, MD, MS; Heidi Sucharew, PhD; Jane Khoury, PhD; Achala Vagal, MD, MS; Pamela A. Schmit, RN, BSN; Irene Ewing, RN, BSN; Steven R. Levine, MD; Stacie Demel, DO, PhD; Bryan Eckerle, MD; Brian Katz, MD; Dawn Kleindorfer, MD; Brian Stettler, MD; Daniel Woo, MD, MS; Pooja Khatri, MD, MSc; Joseph P. Broderick, MD; Arthur M. Pancioli, MD Clinical Implications of Changes in Individual Platelet Reactivity to Aspirin Over Time in Acute Ischemic Stroke Joon-Tae Kim, MD, PhD; Suk-Hee Heo, MD; Kang-Ho Choi, MD; Tai-Seung Nam, MD; Seong-Min Choi, MD; Seung-Han Lee, MD; Man-Seok Park, MD; Byeong C. Kim, MD; Myeong-Kyu Kim, MD; Jeffrey L. Saver, MD, PhD; Ki-Hyun Cho, MD Low-Versus Standard-Dose Alteplase for Ischemic Strokes Within 4.5 Hours: A Comparative Effectiveness and Safety Study Beom Joon Kim, MD; Moon-Ku Han, MD; Tai Hwan Park, MD; Sang-Soon Park, MD; Kyung Bok Lee, MD; Byung-Chul Lee, MD; Kyung-Ho Yu, MD; Mi Sun Oh, MD; Jae Kwan Cha, MD; Dae-Hyun Kim, MD; Jun Lee, MD; Soo Joo Lee, MD; Youngchai Ko, MD; Jong-Moo Park, MD; Kyusik Kang, MD; Yong-Jin Cho, MD; Keun-Sik Hong, MD; Joon-Tae Kim, MD; Jay Chol Choi, MD; Dong-Eog Kim, MD; Dong-Ick Shin, MD; Wook-Joo Kim, MD; Juneyoung Lee, PhD; Ji Sung Lee, PhD; Byung-Woo Yoon, MD; Philip B. Gorelick, MD, MPH; Hee-Joon Bae, MD, PhD Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke Etsuro Mori, MD, PhD; Kazuo Minematsu, MD, PhD; Jyoji Nakagawara, MD, PhD; Yasuhiro Hasegawa, MD, PhD; Shinji Nagahiro, MD, PhD; Yasushi Okada, MD, PhD; Thomas Truelsen, MD, DMSc; Annika Lindsten, BSc; Akira Ogawa, MD, PhD; Takenori Yamaguchi, MD; on behalf of DIAS-J Investigators Non Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis Kang-Ling Wang, MD; Gregory Y.H. Lip, MD; Shing-Jong Lin, MD, PhD; Chern-En Chiang, MD, PhD Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID? Seemant Chaturvedi, MD; Tanya N. Turan, MD; Michael J. Lynn, MS; Colin P. Derdeyn, MD; David Fiorella, MD, PhD; L. Scott Janis, PhD; Marc I. Chimowitz, MBChB; for the SAMMPRIS Trial Investigators Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke Charlotte Andersson, MD, PhD; Sarah R. Preis, ScD; Alexa Beiser, PhD; Charles DeCarli, MD; Kai C. Wollert, MD; Thomas J. Wang, MD; James L. Januzzi Jr, MD; Ramachandran S. Vasan, MD; Sudha Seshadri, MD Deferoxamine, Cerebrovascular Hemodynamics, and Vascular Aging: Potential Role for Hypoxia-Inducible Transcription Factor-1 Regulated Pathways Farzaneh A. Sorond, MD, PhD; Can Ozan Tan, PhD; Sarah LaRose, BA; Andrew D. Monk, BS; Raina Fichorova, MD, PhD; Stanthia Ryan, BS; Lewis A. Lipsitz, MD Spouses of Stroke Survivors Report Reduced Health-Related Quality of Life Even in Long-Term Follow-Up: Results From Sahlgrenska Academy Study on Ischemic Stroke Josefine Persson, MSc; Lukas Holmegaard, MD, MSc; Ingvar Karlberg, MD, PhD; Petra Redfors, MD, PhD; Katarina Jood, MD, PhD; Christina Jern, MD, PhD; Christian Blomstrand, MD, PhD; Gunilla Forsberg-Wärleby, Reg. OT, PhD Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke Jeban Ganesalingam, MBBS, MRCP (Neuro), PhD; Elena Pizzo, PhD; Stephen Morris, PhD; Tom Sunderland, MSc; Diane Ames, MBBS, FRCP; Kyriakos Lobotesis, MBBS, FRCR

4 Basic Sciences Neurorestorative Therapy of Stroke in Type 2 Diabetes Mellitus Rats Treated With Human Umbilical Cord Blood Cells Tao Yan, PhD; Poornima Venkat, BS; Michael Chopp, PhD; Alex Zacharek, MS; Ruizhuo Ning, MD; Yisheng Cui, BS; Cynthia Roberts, BS; Nicole Kuzmin-Nichols, BS, MBA; Cyndy Davis Sanberg, PhD; Jieli Chen, MD Role of Neurexin-1β and Neuroligin-1 in Cognitive Dysfunction After Subarachnoid Hemorrhage in Rats Haitao Shen, MM; Zhouqing Chen, MM; Yang Wang, MM; Anju Gao, MM; Haiying Li, PhD; Yonghua Cui, MD; Li Zhang, MD; Xiang Xu, MM; Zhong Wang, MD; Gang Chen, MD, PhD Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke Sandra A. Acosta, PhD; Naoki Tajiri, PhD; Jaclyn Hoover, MS; Yuji Kaneko, PhD; Cesar V. Borlongan, PhD Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia Lijuan Han, MD; Wei Cai, MD; Leilei Mao, MD, PhD; Jia Liu, MD; Peiying Li, MD, PhD; Rehana K. Leak, PhD; Yun Xu, MD; Xiaoming Hu, MD, PhD; Jun Chen, MD Activation of Dopamine D2 Receptor Suppresses Neuroinflammation Through αb-crystalline by Inhibition of NF-κB Nuclear Translocation in Experimental ICH Mice Model Yang Zhang, MD, PhD; Yujie Chen, MD, PhD; Jiang Wu, MD; Anatol Manaenko, PhD; Peng Yang, MD; Jiping Tang, MD, PhD; Weiling Fu, MD, PhD; John H. Zhang, MD, PhD Recombinant ADAMTS 13 Attenuates Brain Injury After Intracerebral Hemorrhage Ping Cai, PhD; Haiyu Luo, BS; Haochen Xu, BS; Ximin Zhu, MS; Wenfang Xu, BS; Yiqin Dai, MS; Jin Xiao, BS; Yongliang Cao, BS; Yuwu Zhao, MD; Bing-Qiao Zhao, MD, PhD; Wenying Fan, MD, PhD Brief Reports Vascular Neurologists as Directors of Stroke Centers in the United States Lucas Ramirez, MD; Aaron Krug, BS; Heng Nhoung, BS; Suzie Kazaryan, BS; Gregory Gasparian, BA; Joshua Perese, BA; Ali Razmara, MD; David S. Liebeskind, MD; Jennifer J. Majersik, MD, MS; Nerses Sanossian, MD Cavernous Sinus Thrombosis in Children: Imaging Characteristics and Clinical Outcomes Craig A. Press, MD, PhD; Aaron Lindsay, MD; Nicholas V. Stence, MD; Laura Z. Fenton, MD; Timothy J. Bernard, MD; David M. Mirsky, MD White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive Decline Marije R. Benedictus, MSc; Argonde C. van Harten, PhD; Annebet E. Leeuwis, MSc; Teddy Koene, MSc; Philip Scheltens, PhD; Frederik Barkhof, PhD; Niels D. Prins, PhD; Wiesje M. van der Flier, PhD Altered Fibrin Clot Properties in Patients With Cerebral Venous Sinus Thrombosis: Association With the Risk of Recurrence Jakub Siudut, MSc; Maciej Świat, MD, PhD; Anetta Undas, MD, PhD Increase in [ 18 F]-Fluoroacetate Uptake in Patients With Chronic Hemodynamic Cerebral Ischemia Hiroshi Yamauchi, MD, PhD; Shinya Kagawa, MS; Yoshihiko Kishibe, RT; Masaaki Takahashi, RT; Ryuichi Nishii, MD, PhD; Hiroshi Mizuma, PhD; Kazuhiro Takahashi, PhD; Hirotaka Onoe, PhD; Tatsuya Higashi, MD, PhD Stroke and Neurodegeneration Induce Different Connectivity Aberrations in the Insula Indira García-Cordero, PhD; Lucas Sedeño, PhD; Daniel Fraiman, PhD; Damian Craiem, PhD; Laura Alethia de la Fuente, MSc; Paula Salamone, PhD; Cecilia Serrano, MD; Luciano Sposato, PhD; Facundo Manes, PhD; Agustín Ibañez, PhD Hypotension During Endovascular Treatment of Ischemic Stroke Is a Risk Factor for Poor Neurological Outcome Pia Löwhagen Hendén, MD; Alexandros Rentzos, MD; Jan-Erik Karlsson, MD, PhD; Lars Rosengren, MD, PhD; Henrik Sundeman, MD, PhD; Björn Reinsfelt, MD, PhD; Sven-Erik Ricksten, MD, PhD Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke Georgios Tsivgoulis, MD, PhD; Pavla Kadlecová, MS; Adam Kobayashi, MD, PhD; Anna Czlonkowska, MD, PhD; Miroslav Brozman, MD, PhD; Viktor Švigelj, MD; Laszlo Csiba, MD, PhD; Janika Kõrv, MD, PhD; Vida Demarin, MD, PhD; Aleksandras Vilionskis, MD; Dalius Jatuzis, MD, PhD; Aristeidis H. Katsanos, MD; Jobst Rudolf, MD, PhD; Yakup Krespi, MD; Robert Mikulik, MD, PhD

5 Dabigatran Therapy in Acute Ischemic Stroke Patients Without Atrial Fibrillation Mahesh Kate, DM; Laura Gioia, MD; Brian Buck, MD; Leka Sivakumar, MSc; Thomas Jeerakathil, MD; Ashfaq Shuaib, MD; Kenneth Butcher, MD, PhD Occurrence and Predictors of Falls in People With Stroke: Six-Year Prospective Study Lisbeth Rosenbek Minet, PhD; Elizabeth Peterson, PhD; Lena von Koch, PhD; Charlotte Ytterberg, PhD Effects of Postconditioning on Neurogenesis and Angiogenesis During the Recovery Phase After Focal Cerebral Ischemia Elga Esposito, PhD; Kazuhide Hayakawa, PhD; Takakuni Maki, MD, PhD; Ken Arai, PhD; Eng H. Lo, PhD Comments and Opinions Outcome Following Decompressive Hemicraniectomy for Malignant Cerebral Infarction: Ethical Considerations Stephen Honeybul, FRCS (SN), FRACS; Kwok Ming Ho, FCICM, PhD; Grant Gillett, MSc, MB ChB(Auck), DPhil(Oxf), FRACS, FRSNZ Topical Reviews Minimally Invasive Microsurgery for Cerebral Aneurysms Johnny Ho Yin Wong, PhD; Rachel Tymianski; Ivan Radovanovic, PhD; Michael Tymianski, MD, PhD Treatment Concepts for Wake-Up Stroke and Stroke With Unknown Time of Symptom Onset Götz Thomalla, MD; Christian Gerloff, MD Palliative Care: A Core Competency for Stroke Neurologists Claire J. Creutzfeldt, MD; Robert G. Holloway, MD, MPH; J. Randall Curtis, MD, MPH State-of-the-Science Nursing Review Temperature Management and Nursing Care of the Patient With Acute Ischemic Stroke Pimen Kurashvili, MD; DaiWai Olson, PhD, RN Web Site Feature... Stroke Literature Synopses: Clinical Science Michelle P. Lin, MD, MPH; Amytis Towfighi, MD Web Site Feature... Illustrative Teaching Cases Inflammatory Cerebral Amyloid Angiopathy, Amyloid-β Related Angiitis, and Primary Angiitis of the Central Nervous System: Similarities and Differences Aimen Moussaddy, MD; Ariel Levy, MD, FRCP; Daniel Strbian, MD, PhD; Sophia Sundararajan, MD, PhD; France Berthelet, MD, FRCP; Sylvain Lanthier, MD, OD, CSPQ Web Site Feature... Organizational Update Organizational Update: Report From the European Stroke Organisation 2015 Kennedy R. Lees, MD; Valeria Caso, MD; Urs Fischer, MD Web Site Feature... e205 e208 e210 e214 Letters to the Editor Letter by van Klei and Dieleman Regarding Article, Type of Anesthesia and Differences in Clinical Outcome After Intra-Arterial Treatment for Ischemic Stroke Wilton A. van Klei, MD, PhD; Jan M. Dieleman, MD Web Site Feature... e216 Letter by Campbell and Short Regarding Article, Type of Anesthesia and Differences in Clinical Outcome After Intra-Arterial Treatment for Ischemic Stroke Doug Campbell, MD, FRCA, FANZCA; Timothy G. Short, MB, ChB, MD, FANZCA Web Site Feature... e217 Response to Letter Regarding Article, Type of Anesthesia and Differences in Clinical Outcome After Intra-Arterial Treatment for Ischemic Stroke Lucie A. van den Berg, MD; Yvo B.W.E.M. Roos, MD, PhD Web Site Feature... e218

6 Letter by Rebello et al Regarding Article, Cryptic Loss of Consciousness in a 36-Year-Old Woman Letícia C. Rebello, MD; Diogo C. Haussen, MD; Raul G. Nogueira, MD Web Site Feature... e219 Response to Letter Regarding Article, Cryptic Loss of Consciousness in a 36-Year-Old Woman Nicolas Martinez-Majander, MD; Jukka Putaala, MD, PhD, MSc (Stroke Med) Web Site Feature... e220 Letter by Spence Regarding Article, Diet and Stroke: Recent Evidence Supporting a Mediterranean-Style Diet and Food in the Primary Prevention of Stroke J. David Spence, MD Web Site Feature... e221 Corrections Web Site Feature... e222 e223 On the cover: The image is taken from an article in this issue, Minimally Invasive Microsurgery for Cerebral Aneurysms by Wong et al (Stroke. 2015;46: ). The image is Figure 2D.

Original Group Gap Analysis Report

Original Group Gap Analysis Report Original Group Gap Analysis Report Year 11 Levels of Progress Analysis 2014-2015 Spring This document was created using the Transition Matrices Report Generator Copyright Dr Stuart Atkinson - 2014 - All

More information

What s New in Stroke?

What s New in Stroke? 5 th McMaster University Review Course in INTERNAL MEDICINE What s New in Stroke? Robert Hart, M.D. HHS / McMaster Stroke Program Department of Medicine (Neurology) McMaster University Hamilton, Ontario

More information

AHA/ASA Scientific Statement Oral Antithrombotic Agents for the Prevention of Stroke in Atrial Fibrillation

AHA/ASA Scientific Statement Oral Antithrombotic Agents for the Prevention of Stroke in Atrial Fibrillation AHA/ASA Scientific Statement Oral Antithrombotic Agents for the Prevention of Stroke in Atrial Fibrillation A Statement for Healthcare Professionals from the American Heart Association/American Stroke

More information

Therapeutic Management Options for. Acute Ischemic Stroke Anna Rosenbaum, MD

Therapeutic Management Options for. Acute Ischemic Stroke Anna Rosenbaum, MD Therapeutic Management Options for Acute Ischemic Stroke Anna Rosenbaum, MD Epidemiology Epidemiology 4 th leading cause of death in the United States 1 Leading cause of disability Increase in projected

More information

STROKE April 2011 Dr Amer Jafar A delay in recognizing early warning signs (WS) and risk factors (RF) of ischemic stroke causes a delay in treatment Evaluated: knowledge of RF and WS and the impact of

More information

Swedish Initiative for Research on Microdata in the Social And Medical Sciences

Swedish Initiative for Research on Microdata in the Social And Medical Sciences Swedish Initiative for Research on Microdata in the Social And Medical Sciences www.simsam.nu GOCARTS Kardiovaskulär epidemiologi hjärtinfarkt och stroke www.registerforskning.se GOCARTs (Gothenburg CArdiovascular

More information

The author has no disclosures

The author has no disclosures Mary Bradbury, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Surgery September 18, 2012 Mary.bradbury@inova.org This presentation will discuss unlabeled and investigational use of products The author

More information

The Best Lawyers in America 2008

The Best Lawyers in America 2008 The Best Lawyers in America 2008 Alston & Bird Atlanta Pinney L. Allen (10) Randall L. Allen Douglas S. Arnold Peter Q. Bassett R. Neal Batson (20) Alternative Dispute Resolution Jay D. Bennett Alternative

More information

Anticoagulation before and after cardioversion; which and for how long

Anticoagulation before and after cardioversion; which and for how long Anticoagulation before and after cardioversion; which and for how long Sameh Samir, MD Cardiovascular medicine dept. Tanta faculty of medicine Atrial fibrillation goals of management Identify and treat

More information

The Best Lawyers in America 2009

The Best Lawyers in America 2009 The Best Lawyers in America 2009 Alston + Bird Atlanta Randall L. Allen Antitrust Law Douglas S. Arnold Peter Q. Bassett R. Neal Batson Alternative Dispute Resolution Albert E. Bender, Jr. Jay D. Bennett

More information

Emerging therapies for Intracerebral Hemorrhage

Emerging therapies for Intracerebral Hemorrhage Emerging therapies for Intracerebral Hemorrhage Chitra Venkat, MBBS, MD, MSc. Associate Professor of Neurology and Neurological Sciences Stroke and Neurocritical Care. Stanford University Learning objectives

More information

The 2014-2016 Board of Directors

The 2014-2016 Board of Directors The 2014-2016 Board of Directors President Yang, Honggang, Ph.D. 杨 红 钢 Dean, School of Humanities and Social Sciences Nova Southeastern University yangh@nova.edu Vice President Chen, Jie, Ph.D. 陈 捷 Dean,

More information

Marcel Arnold, MD Neurology University of Bern, Switzerland Phone +41 31 632 10 72 marcel.arnold@insel.ch

Marcel Arnold, MD Neurology University of Bern, Switzerland Phone +41 31 632 10 72 marcel.arnold@insel.ch Organizing Committee Marcel Arnold, MD Neurology Phone +41 31 632 10 72 marcel.arnold@insel.ch Caspar Brekenfeld, MD Neuroradiology Phone +41 31 632 26 54 caspar.brekenfeld@insel.ch Jan Gralla, MD, M.Sc

More information

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Connie N. Hess, MD, MHS, Stefan James, MD, PhD, Renato D. Lopes, MD, PhD, Daniel M. Wojdyla,

More information

Developing a Dynamic Team Approach to Stroke Care. Emergency Medical Services 2015

Developing a Dynamic Team Approach to Stroke Care. Emergency Medical Services 2015 Developing a Dynamic Team Approach to Stroke Care Emergency Medical Services 2015 Why Stroke, Why now? A recent study showed that 80 percent of people in the United States live within an hour s drive of

More information

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE CASE REPORT: ACUTE STROKE MANAGEMENT 90 YEAR OLD WOMAN, PREVIOUSLY ACTIVE AND INDEPENDENT, CHRONIC ATRIAL FIBRILLATION,

More information

Chronic kidney disease and cerebral small vessel disease

Chronic kidney disease and cerebral small vessel disease Chronic kidney disease and cerebral small vessel disease M. Arfan Ikram, MD PhD Department of Epidemiology, Radiology, Neurology Erasmus MC Rotterdam, The Netherlands No disclosures Kidney-brain: Two pulsating

More information

The International Agenda for Stroke

The International Agenda for Stroke 1st Global Conference on Healthy Lifestyles and Noncommunicable Diseases Control Moscow, 28-29 April, 2011 The International Agenda for Stroke Marc Fisher MD, University of Massachusetts Editor-in-Chief,

More information

AR SAVES. INTRODUCTION AND UPDATES FOR ER PHYSICIANS. Nicolas Bianchi, MD. August 23 rd, 2012.

AR SAVES. INTRODUCTION AND UPDATES FOR ER PHYSICIANS. Nicolas Bianchi, MD. August 23 rd, 2012. 1 AR SAVES INTRODUCTION AND UPDATES FOR ER PHYSICIANS. Nicolas Bianchi, MD. August 23 rd, 2012. 2 Objectives To provide an introduction and overall description of AR SAVES as a Telestroke Network in the

More information

Virginia Commonwealth University Premedical Graduate Certificate Program Class of 2015

Virginia Commonwealth University Premedical Graduate Certificate Program Class of 2015 Kirsti Allen Veena Aswath Jessica Aynapudi of Texas Noah Belkhayat Ines Benothmane Brittany Benton Elizabeth Booth Chad Cain Patrick Brown of Georgia Emory Tiffany Chu Michael Chung Lauren Clark Daniel

More information

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor

More information

Malmö Preventive Project. Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints Malmö Preventive Project Department of Clinical Sciences Malmö University Hospital Lund University Malmö Preventive Project Cardiovascular Endpoints End of follow-up: 31 Dec 2008 * Report: 21 June 2010

More information

Curriculum Vitae. Soumitra Bhuyan, PhD, MPH. Division of Health Systems Management and Policy January, 2015

Curriculum Vitae. Soumitra Bhuyan, PhD, MPH. Division of Health Systems Management and Policy January, 2015 1 Curriculum Vitae Soumitra Bhuyan, PhD, MPH Division of Health Systems Management and Policy January, 2015 School of Public Health (901)-678-3740 (Office) The University of Memphis sbhuyan@memphis.edu

More information

STROKE PREVENTION IN ATRIAL FIBRILLATION

STROKE PREVENTION IN ATRIAL FIBRILLATION STROKE PREVENTION IN ATRIAL FIBRILLATION OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention of ischemic stroke and arterial thromboembolism in patients

More information

STROKE TRAINING FOR EMS PROFESSIONALS

STROKE TRAINING FOR EMS PROFESSIONALS 1 STROKE TRAINING FOR EMS PROFESSIONALS COURSE OBJECTIVES About Stroke Stroke Policy Recommendations Stroke Protocols and Stroke Hospital Care Stroke Assessment Tools Pre-Notification Stroke Treatment

More information

Brooklyn Stroke Symposium 2015

Brooklyn Stroke Symposium 2015 Brooklyn Stroke Symposium 2015 May 28, 2015 Brooklyn Public Library Grand Army Plaza Sponsored by Keynote Presentations Sleep Apnea and Stroke: More than a Snore Devin L. Brown, M.D., M.S. Professor of

More information

2016 International Stroke Conference Hot Topics Lori M. Massaro, MSN, CRNP Kari Moore, MSN, AGACNP-BC

2016 International Stroke Conference Hot Topics Lori M. Massaro, MSN, CRNP Kari Moore, MSN, AGACNP-BC 2016 International Stroke Conference Hot Topics Lori M. Massaro, MSN, CRNP Kari Moore, MSN, AGACNP-BC Disclosures Lori M. Massaro, MSN,CRNP speakers bureau Genentech Kari Moore, MSN, AGACNP-BC -none 1

More information

Level III Stroke Center Data Collection Requirements

Level III Stroke Center Data Collection Requirements Who? Level III Stroke Center Data Collection Requirements All LERN Level III Stroke Centers. LERN Level I and II Stroke Centers have reporting requirements to The Joint Commission or other Board approved

More information

Cardiovascular Endpoints

Cardiovascular Endpoints The Malmö Diet and Cancer Study Department of Clinical Sciences Malmö University Hospital Lund University The Malmö Diet and Cancer Study CV-cohort Cardiovascular Endpoints End of follow-up: 31 Dec * Report:

More information

Chapter 3: Review of Literature Stroke

Chapter 3: Review of Literature Stroke Chapter 3: Review of Literature Stroke INTRODUCTION Cerebrovascular accident (also known as stroke) is a serious health problem in the United States and a leading cause of long-term disability. In this

More information

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for

More information

DEPARTMENTAL PROFILES, 2015-2016

DEPARTMENTAL PROFILES, 2015-2016 DIVISION OF THE ARTS DEPARTMENTAL PROFILES, 2015-2016 Art, Art History, and Design 16 T&R faculty 4 professional specialists, M.A. in Art History; B.A., B.F.A. and M.F.A. in Art Studio and Design. Chairperson,

More information

Do We Need a New Definition of Stroke & TIA as Proposed by the AHA? Stroke & TIA need to Remain Clinical Diagnoses: to Change Would be Bonkers!

Do We Need a New Definition of Stroke & TIA as Proposed by the AHA? Stroke & TIA need to Remain Clinical Diagnoses: to Change Would be Bonkers! Do We Need a New Definition of Stroke & TIA as Proposed by the AHA? No Stroke & TIA need to Remain Clinical Diagnoses: to Change Would be Bonkers! A/Prof Anne L. Abbott Neurologist School of Public Health

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

Date: 6/30/2015 1:14 pm Rutherford County Chancery Court - 20 N. Public Square Room 302Judicial Building Murfreesboro, TN 37130 User: Raechelle

Date: 6/30/2015 1:14 pm Rutherford County Chancery Court - 20 N. Public Square Room 302Judicial Building Murfreesboro, TN 37130 User: Raechelle Date: 6/30/2015 1:14 pm Rutherford County Chancery Court - 20 N. Public Square Room 302Judicial Building Murfreesboro, TN 37130 Page 1 of 7 User: Raechelle Civil Court Docket Sorted By: Hearing Date/Time-Case

More information

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7

More information

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological

More information

The Neuro-ICU Symposium Cutting-edge Management of Neurological / Neurosurgical Emergencies and Critical Care

The Neuro-ICU Symposium Cutting-edge Management of Neurological / Neurosurgical Emergencies and Critical Care The Neuro-ICU Symposium Cutting-edge Management of Neurological / Neurosurgical Emergencies and Critical Care The First Annual Meeting: Saving lives beyond expectation March 6-8, 2013 The University of

More information

Perioperative Bridging in Atrial Fibrillation: Is it necessary?

Perioperative Bridging in Atrial Fibrillation: Is it necessary? Perioperative Bridging in Atrial Fibrillation: Is it necessary? Jason B. Thompson M.D., Ph.D. August 29, 2015 2015 NCVH Birmingham Hypothesis: When bridging, risk of bleeding < risk systemic embolism (SE).

More information

Comprehensive Stroke Center Certification

Comprehensive Stroke Center Certification Comprehensive Stroke Center Certification July 17, 2012 Today s Agenda Welcome and Introductory Comments Standards and Eligibility Questions and Answers Performance Measurement Questions and Answers On-Site

More information

3 rd ESO Stroke Science Workshop Garmisch-Partenkirchen, Germany, Hotel Eibsee

3 rd ESO Stroke Science Workshop Garmisch-Partenkirchen, Germany, Hotel Eibsee 3 rd ESO Stroke Science Workshop Garmisch-Partenkirchen, Germany, Hotel Eibsee November 19-21, 2015 Conference Chairs: Heinrich Mattle, Martin Dichgans Organizing Committee: Martin Dichgans (Munich), Kennedy

More information

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation

More information

Stroke Risk Scores. CHA 2 DS 2 -VASc. CHA 2 DS 2 -VASc Scoring Table 2

Stroke Risk Scores. CHA 2 DS 2 -VASc. CHA 2 DS 2 -VASc Scoring Table 2 Bleeding/Clotting Risk Evaluation Tools for Atrial Fibrillation Patients Before prescribing anticoagulants, providers should weigh the risk of thrombosis against the risk of bleeding. The tools below can

More information

Stroke Update Symposium

Stroke Update Symposium PRESENTS: Stroke Update Symposium Friday, November 16, 2012 7:45am-5:00pm Hilton Garden Inn-Levis Commons, Perrysburg, OH The American Heart Association estimates 700,000 Americans each year suffer a new

More information

Let s talk about: Stroke

Let s talk about: Stroke Let s talk about: Stroke February 20 th 2013 Laura Wilson Christine Stables Questions 1. Why is knowing about stroke important? 2. What exactly is a stroke and what are the symptoms? 3. What should I do

More information

en fi lm af Zhang Yang instruktøren bag den kinesiske fi lmperle Badeanstalten Premiere 31. oktober

en fi lm af Zhang Yang instruktøren bag den kinesiske fi lmperle Badeanstalten Premiere 31. oktober produced by Harvey Wong, Liu Qiang producer Stanley Tong co-producer Michael J. Werner, Wouter Barendrecht producer Er Yong, Zhang Yang screenplay by Zhang Yang, Wang Yao director Zhang Yang Line producer

More information

Malmö Preventive Project. Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints Malmö Preventive Project Department of Clinical Sciences Skåne University Hospital, Malmö Lund University Malmö Preventive Project Cardiovascular Endpoints End of follow-up: 30 June 2009 Report: 7 October

More information

Workshop on Internet and BigData Finance (WIBF)

Workshop on Internet and BigData Finance (WIBF) Workshop on Internet and BigData Finance (WIBF) Central University of Finance and Economics June 11-12, 2015 In a 2013 study, IBM found that 71 percent of the banking and financial firms report that the

More information

STROKE OCCURRENCE SYMPTOMS OF STROKE

STROKE OCCURRENCE SYMPTOMS OF STROKE STROKE OCCURRENCE SYMPTOMS OF STROKE The symptoms of stroke depend on what part of the brain is affected and how large an area is involved. A stroke is a sudden event accompanied by one or more of the

More information

Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation

Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation Drew Baldwin, MD Virginia Mason Seattle, Washington NCVH May 29,

More information

MEMORANDUM. and. The Remaining Members of the Board of Visitors: A. Macdonald Caputo Robert D. Hardie

MEMORANDUM. and. The Remaining Members of the Board of Visitors: A. Macdonald Caputo Robert D. Hardie November 15, 2010 MEMORANDUM TO: The Transitional Care Hospital Board: Vincent J. Mastracco Jr., Chair Helen E. Dragas Sheila C. Johnson William P. Kanto Jr., M.D. Constance R. Kincheloe Randy J. Koporc

More information

Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy

Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Judith Long, MD,RWJCS Perelman School of Medicine Philadelphia Veteran Affairs Medical Center Background Objective Overview Methods

More information

AHA/ASA Scientific Statement

AHA/ASA Scientific Statement AHA/ASA Scientific Statement Metrics for Measuring Quality of Care in Comprehensive Stroke Centers: Detailed Follow-Up to Brain Attack Coalition Comprehensive Stroke Center Recommendations A Statement

More information

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium October 30, 2008 Barry Libman, RHIA, CCS, CCS-P President, Barry Libman Inc. Stroke Coding Issues Outline Medical record documentation

More information

Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies

Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies Overview Where We Use It And Why Andreas Antoniou, M.D., M.Sc. Department of Anesthesia and Perioperative Medicine University of Western Ontario November 14 th, 2009 Hemostasis Fibrinolysis Aprotinin and

More information

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS M.D.L. NO. 1430 CIVIL ACTION NO. 01-10861 IN RE LUPRON MARKETING AND SALES PRACTICES LITIGATION

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS M.D.L. NO. 1430 CIVIL ACTION NO. 01-10861 IN RE LUPRON MARKETING AND SALES PRACTICES LITIGATION Case 1:01-cv-10861-RGS Document 585 Filed 04/01/14 Page 1 of 6 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS M.D.L. NO. 1430 CIVIL ACTION NO. 01-10861 IN RE LUPRON MARKETING AND SALES PRACTICES

More information

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre GP workshop Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre Stroke: the Facts Stroke: the Facts Every 5 minutes someone in the UK has a stroke 1 in 4 men and 1 in 5 women will have a stroke

More information

APPENDIX A NEUROLOGIST S GUIDE TO USING ICD-9-CM CODES FOR CEREBROVASCULAR DISEASES INTRODUCTION

APPENDIX A NEUROLOGIST S GUIDE TO USING ICD-9-CM CODES FOR CEREBROVASCULAR DISEASES INTRODUCTION APPENDIX A NEUROLOGIST S GUIDE TO USING ICD-9-CM CODES FOR CEREBROVASCULAR DISEASES INTRODUCTION ICD-9-CM codes for cerebrovascular diseases is not user friendly. This presentation is designed to assist

More information

This program is cosponsored by the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL).

This program is cosponsored by the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL). PROFICIENCY TESTING TREC Quarterly Report Volume 4, No. 4 November 2014 INTRODUCTION This report is the Quarterly summary of all data reported within the specified data-reporting period for the Quarter

More information

Cardiovascular Endpoints

Cardiovascular Endpoints The Malmö Diet and Cancer Study Department of Clinical Sciences Skåne University Hospital, Malmö Lund University The Malmö Diet and Cancer Study CV-cohort Cardiovascular Endpoints End of follow-up: 30

More information

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of

More information

Blood thinning (anticoagulation) in atrial fibrillation (AF)

Blood thinning (anticoagulation) in atrial fibrillation (AF) AF A Blood thinning (anticoagulation) in atrial fibrillation (AF) Providing information, support and access to established, new or innovative treatments for atrial fibrillation www.afa.org.uk Registered

More information

Development of Smartphone Application That Aids Stroke Screening and Identifying Nearby Acute Stroke Care Hospitals

Development of Smartphone Application That Aids Stroke Screening and Identifying Nearby Acute Stroke Care Hospitals Original Article http://dx.doi.org/10.3349/ymj.2014.55.1.25 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 55(1):25-29, 2014 Development of Smartphone Application That Aids Stroke Screening and Identifying

More information

82 Fennemore Craig Attorneys Named to Best Lawyers in America 2014

82 Fennemore Craig Attorneys Named to Best Lawyers in America 2014 Contact: Whitney Murray Fennemore Craig (602) 916-5290 wemurray@fclaw.com Press Release For Immediate Release August 15, 2013 82 Fennemore Craig Attorneys Named to Best Lawyers in America 2014 PHOENIX,

More information

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012 Faculty Prevention Sharon Ewer, RN, BSN, CNRN Stroke Program Coordinator Baptist Health Montgomery, Alabama Satellite Conference and Live Webcast Monday, May 21, 2012 2:00 4:00 p.m. Central Time Produced

More information

Research Paper: Stroke

Research Paper: Stroke 2016 Research Paper: Stroke STEP NUS SUNBURST BRAIN CAMP NG XIN NI, XIE JIAYING, YEE TING HUI, ZHANG QING YANG RIVER VALLEY HIGH SCHOOL Contents 1. INTRODUCTION... 2 1.1. IMPORTANCE OF UNDERSTANDING STROKE...

More information

Advances in Stroke Care

Advances in Stroke Care Advances in Stroke Care 2015 Friday October 2 7 a.m. to 4:30 p.m. Hyatt Regency New Brunswick Two Albany Street New Brunswick, NJ 08901 Jointly sponsored by the Comprehensive Stroke Center Robert Wood

More information

JHS Stroke Program. 2016 JHS Annual Mandatory Education

JHS Stroke Program. 2016 JHS Annual Mandatory Education JHS Stroke Program 2016 JHS Annual Mandatory Education Learner Objectives At the conclusion of this module learners will be able to: State the definition of stroke Discuss the pathophysiology of stroke

More information

Anticoagulants in Atrial Fibrillation

Anticoagulants in Atrial Fibrillation Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives

More information

What Is an Arteriovenous Malformation (AVM)?

What Is an Arteriovenous Malformation (AVM)? What Is an Arteriovenous Malformation (AVM)? From the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council Randall T. Higashida, M.D., Chair 1 What

More information

9/5/14. Objectives. Atrial Fibrillation (AF)

9/5/14. Objectives. Atrial Fibrillation (AF) Novel Anticoagulation for Prevention of Stroke in Patients with Atrial Fibrillation Objectives 1. Review current evidence on use of warfarin in individuals with atrial fibrillation 2. Compare the three

More information

FOR THE PREVENTION OF ATRIAL FIBRILLATION RELATED STROKE

FOR THE PREVENTION OF ATRIAL FIBRILLATION RELATED STROKE www.bpac.org.nz keyword: warfarinaspirin FOR THE PREVENTION OF ATRIAL FIBRILLATION RELATED STROKE Key Concepts In atrial fibrillation (AF) warfarin is more effective than aspirin for stroke prevention.

More information

2011 Canadian Open Taiji Championships - Toalu Score

2011 Canadian Open Taiji Championships - Toalu Score CHAN STYLE 56 FORMS Iggy Lam Advance Ji Hong Tai Chi (Scar) Chen Style 56 forms 7.83 Franklin Mok Advance Ji Hong Tai Chi (Scar) Chen Style 56 forms 7.20 Eric Wai Intermediate Ji Hong Tai Chi Chen Style

More information

Appendix: List of Contributors

Appendix: List of Contributors Appendix: List of Contributors Editorial Board Kaveh G. Shojania, MD Assistant Professor Bradford W. Duncan, MD AHRQ Patient Safety Fellow Center for Primary Care & Outcomes Research Stanford University

More information

STATEMENT OF STANDARD

STATEMENT OF STANDARD OHSU HEALTH CARE SYSTEM PRACTICE STANDARD Acute Stroke Practice Standard for the Emergency Department (includes ischemic stroke, TIAs, intracerebral hemorrhage, and non-subarachnoid hemorrhage), PS 01.11

More information

Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model

Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model Robyn Balden & Farida Sohrabji Texas A&M Health Science Center- College of Medicine ISC

More information

Your Guide to Express Critical Illness Insurance Definitions

Your Guide to Express Critical Illness Insurance Definitions Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses

More information

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND: STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention

More information

AANN ADVANCES IN STROKE CARE CONFERENCE

AANN ADVANCES IN STROKE CARE CONFERENCE AANN ADVANCES IN STROKE CARE CONFERENCE September 25 26, 2015 Hilton Rosemont/Chicago O Hare Chicago, IL AANN.org/strokeconference Earn up to 15 contact hours! ANSWERING YOUR CALL FOR MORE STROKE KNOWLEDGE

More information

The importance of adherence and persistence: The advantages of once-daily dosing

The importance of adherence and persistence: The advantages of once-daily dosing The importance of adherence and persistence: The advantages of once-daily dosing Craig I. Coleman, PharmD Professor, University of Connecticut School of Pharmacy Storrs, CT, USA Conflicts of interest Dr

More information

(1) Delivery of a Controlled Substance, Lisdexamfetamine, (2) Delivery of a Controlled Substance, Hydrocodone, a. (1) Battery, a misdemeanor

(1) Delivery of a Controlled Substance, Lisdexamfetamine, (2) Delivery of a Controlled Substance, Hydrocodone, a. (1) Battery, a misdemeanor Lewis County Grand Jury July 2015 ANGUILLI, Joseph Michael BAKER, William Lee (Jr.) BLEIGH, Justin K. a Lisdexamfetamine, a BOLTON, Paul Aaron (methamphetamine) BURNSIDE, Billie Renea BUTCHER, Amber Marie

More information

What You Should Know About Cerebral Aneurysms

What You Should Know About Cerebral Aneurysms What You Should Know About Cerebral Aneurysms From the Cerebrovascular Imaging and Interventions Committee of the American Heart Association Cardiovascular Radiology Council Randall T. Higashida, M.D.,

More information

Novel oral Anticoagulants, stroke and intracerebral hemorrhage

Novel oral Anticoagulants, stroke and intracerebral hemorrhage Novel oral Anticoagulants, stroke and intracerebral hemorrhage David Seiffge and Philippe Lyrer on behalf of the Basel Stroke Research Team: Leo Bonati, Gian Marco De Marchis, Stefan Engelter, Henrik Gensicke,

More information

Contents. Part I. The Context for Public Health Informatics. Part II. The Science of Public Health Informatics. Foreword. Series Preface.

Contents. Part I. The Context for Public Health Informatics. Part II. The Science of Public Health Informatics. Foreword. Series Preface. Contents Foreword Series Preface Preface Acknowledgments Contributors Part I. The Context for Public Health Informatics Chapter 1. Introduction to Public Health Informatics Chapter 2. History and Significance

More information

Vascular Bootcamp for Nurses and Advanced Care Providers

Vascular Bootcamp for Nurses and Advanced Care Providers 2 nd Annual Vascular Bootcamp for Nurses and Advanced Care Providers Saturday, January 24, 2015 8 AM to 3 PM Course Director: S. Knippel, RN, FNP-C Location: Hickey Auditorium, R11.1400 1515 Holcombe Blvd.

More information

Prevention of stroke in patients with atrial fibrillation

Prevention of stroke in patients with atrial fibrillation www.sign.ac.uk Prevention of stroke in patients with atrial fibrillation A guide for primary care January 2014 Evidence Contents 1 Introduction... 1 2 Detection...2 3 Risk stratification... 3 4 Treatment

More information

Stop the Bleeding: Management of Drug-induced Coagulopathy. Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery

Stop the Bleeding: Management of Drug-induced Coagulopathy. Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery Stop the Bleeding: Management of Drug-induced Coagulopathy Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery Objectives Discuss contemporary management of warfarin reversal in patients

More information

WAKEMED HEALTH & HOSPITALS STROKE PROGRAM PRESENTS THE SECOND ANNUAL. TimeisBrain. Advances in Stroke Care Conference

WAKEMED HEALTH & HOSPITALS STROKE PROGRAM PRESENTS THE SECOND ANNUAL. TimeisBrain. Advances in Stroke Care Conference WAKEMED HEALTH & HOSPITALS STROKE PROGRAM PRESENTS THE SECOND ANNUAL TimeisBrain Advances in Stroke Care Conference Thursday, October 18 & Friday, October 19, 2007 RALEIGH, NC The William F. Andrews Center

More information

CDEC FINAL RECOMMENDATION

CDEC FINAL RECOMMENDATION CDEC FINAL RECOMMENDATION RIVAROXABAN (Xarelto Bayer Inc.) Indication: Stroke Prevention in Atrial Fibrillation This recommendation supersedes the Canadian Drug Expert Committee (CDEC) recommendation for

More information

Approximately 70-80% of all strokes are ischemic and 20-30% are hemorrhagic Hemorrhagic stroke is defined as an acute neurologic injury resulting from bleeding in the brain There are two distinct types

More information

The New Oral Anticoagulants: When and When Not to Use Them Philip C. Comp, M.D., Ph.D. Professor of Medicine, University of Oklahoma Health Sciences

The New Oral Anticoagulants: When and When Not to Use Them Philip C. Comp, M.D., Ph.D. Professor of Medicine, University of Oklahoma Health Sciences The New Oral Anticoagulants: When and When Not to Use Them Philip C. Comp, M.D., Ph.D. Professor of Medicine, University of Oklahoma Health Sciences Center September 25, 2015 Question: With which of the

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

Introduction. Methods. Study population

Introduction. Methods. Study population New Technologies, Diagnostic Tools and Drugs Schattauer 2012 1 Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a real world atrial fibrillation

More information

Springer Series in Translational Stroke Research

Springer Series in Translational Stroke Research Springer Series in Translational Stroke Research Series Editor John Zhang For further volumes: http://www.springer.com/series/10064 Jun Chen Xiaoming Hu Mary Stenzel-Poore John H. Zhang Editors Immunological

More information

Are We Too Hesitant to Anticoagulate Elderly Patients with Atrial Fibrillation? A risk-benefit analysis Sunny Shah

Are We Too Hesitant to Anticoagulate Elderly Patients with Atrial Fibrillation? A risk-benefit analysis Sunny Shah The American Journal of Medicine June 11, 2014 http://dx.doi.org/10.1016/j.amjmed.2014.05.035 Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project

More information

OHTAC Recommendation

OHTAC Recommendation OHTAC Recommendation Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency Presented to the Ontario Health Technology Advisory Committee in May 2010 May 2010 Issue Background A review on the

More information

PCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES

PCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES PCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES Why should mood difficulties in individuals with a health condition be addressed? Many people with health conditions also experience mood difficulties

More information

Nancy P. Mendenhall, MD University of Florida Proton Therapy Institute. William M. Mendenhall, MD University of Florida Proton Therapy Institute

Nancy P. Mendenhall, MD University of Florida Proton Therapy Institute. William M. Mendenhall, MD University of Florida Proton Therapy Institute About the Journal Mission The International Journal of Particle Therapy (IJPT) is the official journal of the Particle Therapy Cooperative Group. The mission of IJPT is to provide a preferred venue for

More information

Sanford Health/UNDSMHS Cerebrovascular Symposium

Sanford Health/UNDSMHS Cerebrovascular Symposium Discover. Inspire. Grow. Sanford Health/UNDSMHS Cerebrovascular Symposium January 23, 2016 Ramada Plaza & Suites 1635 42nd Street South Fargo, North Dakota (701) 277-9000 This symposium is supported in

More information

NOVEL ANTICOAGULANTS

NOVEL ANTICOAGULANTS NOVEL ANTICOAGULANTS MAKING EDUCATED GUESSES IN PATIENTS WITH ACUTE ISCHEMIC STROKE IGOR RYBINNIK, M.D. Assistant Professor of Neurology Rutgers Robert Wood Johnson Medical School DISCLOSURES FINANCIAL

More information